key: cord-1008444-rbp4dymu
authors: Ngara, Mtakai; Siwo, Geoffrey Henry
title: Molecular relationships between SARS-CoV-2 Spike protein and LIFR, a pneumonia protective IL-6 family cytokine receptor
date: 2021-04-19
journal: bioRxiv
DOI: 10.1101/2021.04.18.440296
sha: 395a8bb120914730f7fbfec84a3ca420a8185bd4
doc_id: 1008444
cord_uid: rbp4dymu

The fine-tuned control of immune responses is attained by pairs of activating and inhibitory signaling receptors which modulate the quality and magnitude of immune responses. Some viruses exploit these pathways to enter host cells as well as interfere with immune responses. Here, we report that the SARS-CoV-1/2 Spike proteins (S) contain a potential inhibitory tyrosine- based immunoreceptor motif (ITIM) with the D614G variant occurring within this motif. Through an in silico screen of ITIM-containing human proteins, we find that the S-located ITIM is closely related to a previously reported ITIM in the cytoplasmic tail of the human Leukemia Inhibitory Factor Receptor (LIFR), a pneumonia protective IL-6 family cytokine receptor. To infer potential functional interactions between SARS-CoV-2 infection and LIFR expression, we performed single-cell transcriptome analysis of public datasets of lung tissues from healthy individuals and COVID-19 patients. We show that transcripts of LIFR and its ligand LIF are highly expressed in SARS-CoV-2 susceptible lung cells from mild and severe COVID-19 patients but not in healthy individuals. In addition, the human endogenous retroviral envelope gene (ERVW-1) encoding a fusogenic protein of the same functional class as the S protein, is induced in SARS-CoV-2 susceptible cell subpopulations in COVID-19 patients with no detectable expression in healthy individuals. We also report that pulmonary epithelial cells express transcripts of several immunoreceptors including the ITIM-containing antibody receptor FCGR2B which is detectable in healthy and severe COVID-19 cases but not in mild cases. These results suggest that molecular dysregulation of ITIM-mediated inhibitory signaling by the SARS-CoV-2 S protein may play a role in COVID-19 immunopathology.

Coronavirus disease patients exhibit varying degrees of immune system dysfunction including potential cytokine storms 1 , acute respiratory distress syndrome (ARDS) 2 and the production of autoantibodies against several self-antigens [3] [4] [5] . This implicates dysregulation of immune homeostasis and self-tolerance in the pathology of the disease, an area that remains understudied. Central to immune homeostasis is the coordination between activating and inhibitory signaling which ensures proportionate responses to the damage posed by pathogens during infection while maintaining tolerance to self-antigens. In immune cells this is attained by paired cell surface receptors that are either activating or inhibitory in function.

Activating receptors recruit adaptor proteins containing the immunoreceptor tyrosine-based activation motifs (ITAMs) or in some cases contain ITAMs in their own cytoplasmic tails 6 . The ligation and clustering of activating receptors leads to the phosphorylation of ITAMs thereby creating docking sites for SH2-domain containing kinases which subsequently phosphorylate downstream substrates and eventually trigger effector functions such as phagocytosis and production of cytokines 6 . In contrast to activating receptors, inhibitory receptors contain immunoreceptor tyrosine-based inhibitory motifs (ITIM) 7 . Ligation of inhibitory receptors leads to phosphorylation of ITIMs in their cytoplasmic tails followed by the recruitment of SH2-domain containing cytoplasmic phosphatases (SHP2). This process eventually results in the dephosphorylation of downstream effectors and downregulation of immune responses or maintenance of self-tolerance 7 . While ITAMs are typically involved in immune activation they can also be inhibitory in some cases 8 . Certain pathogens including viruses and bacteria can exploit inhibitory signaling, for example, by mimicking ITIM/ITAM sequences in host regulatory receptors to dysregulate immune responses 9, 10 .

We hypothesized that the SARS-CoV-1/2 S proteins could potentially modulate immune signaling pathways through highly conserved short amino sequences that mediate interactions between human proteins, commonly referred to as short linear motifs (SLiMs) [11] [12] [13] . Because of their short nature (3-10 amino acids), SLiMs can rapidly emerge in viral genomes through convergent evolution and enable viral proteins to physically interact with host proteins 14 . Since the S protein is critical for cell entry by coronaviruses, elicits strong neutralizing antibodies, and has been associated with antibody-mediated enhancement (ADE) in SARS-CoV-1 15, 16 , an understanding of its potential role, if any, in subversion of host immune responses is needed.

We investigated whether the SARS-CoV-1/2 S proteins contain specific sequence motifs that could mimic ITIM and ITAM motifs. We focused on these two motifs because: i) They are central to balancing activating and inhibitory signals which is crucial to maintenance of self-tolerance and without which autoimmunity occurs 6 ; ii) The ITAM-containing receptor (FCGR2A) and ITIMcontaining (LILRB1) facilitate dengue virus ADE through binding to antibody F c and by enabling endosomal escape of the virus, respectively [17] [18] [19] [20] ; iii) Some viruses mimic these motifs to downregulate immune responses 9 and, iv) Exogenously delivered synthetic peptides containing ITIM motifs interfere with immune signaling demonstrating that standalone peptides containing ITIM motifs can effectively disrupt inhibitory signaling 21, 22 .

We screened SARS-CoV-1/2 S proteins against the Eukaryotic Linear Motif (ELM) database 23, 24 to identify potential SLiMs that may mediate interactions with components of the immune system. A number of SLiMs associated with interactions involving immune signaling pathways were detected in several host proteins including STAT3, STAT5, TRAF-2 binding motifs, TRAF6 binding site for Tumor Necrosis Factor 6 and ITIM (Supplementary Table 1 ). The vast majority of the identified SLiMs are not directly involved in immune signaling and include the recently identified RGD motif in SARS-CoV-2 S protein that binds to host integrins 25 . Whether some of these identified motifs in the virus are functional will need experimental validation. Here, we focus on the ITIM-like sequence (610-VLYQDV-615, coordinates relative to SARS-CoV-2 S; P = 3e-04) for the following reasons. First, antibodies to SARS-CoV-1 S derived peptide (611-LYQDVN-616) that overlaps the predicted ITIM were previously associated with ADE both in in vitro experiments and in vivo studies in non-human primate 15 . Second, the ITIM containing receptor LILRB1 has been reported to facilitate escape of dengue virus from lysosomal degradation and inhibit induction of interferon stimulated genes (ISGs) during ADE mediated viral entry into cells via the ITAM-containing FCGR2A receptor 19, 20 . While ADE has not been observed in SARS-CoV-2 infections or vaccine recipients, the dysregulation of inhibitory signaling could lead to immunopathological reactions such as autoantibody production and cytokine storms that have been reported in COVID-19 1, 5 . Third, the D614G mutation [26] [27] [28] in SARS-CoV-2 lies within the predicted ITIM motif. Since ITIMs are crucial for inhibitory signaling of immune responses, mimicry by a pathogen could interfere with this process, leading to uncontrolled immune responses. Indeed, a few bacterial and viral proteins containing ITIM sequences have been established to use the motifs to interfere with host immune signaling pathways 9,10,29 .

Next, we asked whether the SARS-CoV-1/2 ITIM motif shares high sequence similarity to ITIMlike sequences located in the cytoplasmic tails of specific human proteins identified by previous computational studies 30 . Out of 109 proteins in the human proteome containing putative ITIM motifs 30 , the LIFR ITIM (VIYIDV) is highly similar to the wild-type SARS-CoV-1/2 ITIM sequence (VLYQDV), with only 2 amino differences between the two. Another host protein with a closely related ITIM is the platelet derived growth factor receptor, beta precursor (PDGFRB) with the sequence VLYTAV 30 . Previous studies indicate that LIFR is required for lung protection during pneumonia, for example, in respiratory syncytial virus infections (RSV) [31] [32] [33] [34] . Furthermore, its ligand, LIF, is one of the cytokines in the IL-6 family and is increased in the lungs of patients with ARDS 35, 36 , which has been observed in COVID-19 patients 2, 37, 38 . Notably, because the D614G variant is located within the SARS-CoV-2 ITIM, the mutational distance between the LIFR ITIM and the corresponding ITIM sequence in D614G viruses increases from 2 to 3 which could reduce the potential molecular mimicry or subversion of LIFR by the D614G associated ITIM. A number of studies suggest that D614G variants are highly transmissible 26, 27, 39, 40 and that the mutation increases infectivity to lung cells [40] [41] [42] [43] [44] [45] [46] implying the possibility that this sequence region is under selective pressure. However, to date no associations have been found between this mutation and COVID-19 disease severity 26, 28 .

To further explore the possibility of biological interactions between LIFR and SARS-CoV-2, we analyzed LIFR expression in single-cell transcriptomes of human tissues using data from the human cell atlas (HCA) 47 and lung single cell transcriptome from the Madissoon et al study 48 as well as a recently published single-cell bronchoalveolar transcriptome of COVID-19 patients and healthy controls 49 ( Fig. 1-2, Supplementary Fig. S1 and S2 ). In addition, we included single-cell expression levels of genes important for SARS-CoV-2 cell entry (ACE2, TMPRSS2, NRP1, NRP2) 50 Additionally, we included ERVW-1 which encodes the human endogenous retrovirus W (HERV-W) envelope protein or syncytin, one of a few host proteins that are functionally similar to the viral spike protein in catalyzing fusion of cell membranes. Further details on the selected genes are described in the Methods section.

The overall expression of the selected target genes across human tissues shows that the key SARS-CoV-2 entry factors (ACE2 and TMPRSS2) are sparsely expressed in normal tissues with the highest detectable single-cell expression of ACE2 in the esophagus (~1.4% of cells) followed by lungs (~0.18% of cells), liver (~0.1% of cells) and eye (~0.05% of cells) (Fig. 1 A, HCA data). As lungs are the primary tissue targeted by SARS-CoV-2, we also analyzed the expression of the selected candidate genes in the Madissoon et al study 48 (Fig. 1B) . The percentage of cells expressing ACE2, TMPRSS2 and LIFR in lung tissue was highly comparable between the HCA and the Madissoon et al study datasets with extremely low ACE2 expression in both. This is consistent with previously published studies 58, 59 . Next, we applied unsupervised approach based on uniform manifold learning (UMAP) 60 Fig. S3 and S4) . Notably, the hypertensive lung was originally identified as healthy in the Madissoon et al study 48 .

Interestingly, the expression levels of the candidate genes from the right and left normal lungs are distinct potentially due to differences in lung volume, implying that gene expression analyses of lung cells need to take this into account. Out of the genes analyzed, ERVW-1 has a unique expression pattern -it is not expressed at all in both left and right normal lungs and is weakly but detectably expressed in the hypertensive lung, and even so only in AET1 and ciliated P1 cells (Fig. 1D ). there appears to be a potential link to SARS-CoV-2 infection.

There is increasing evidence that dysregulation of immune responses plays a critical role in COVID-19 through several mechanisms. For example, autoantibodies against a broad range of extracellular antigens such as cytokines (IFNs, IL6) 3,5 , chemokines (CXCL1, CXCL7) 5 In this study, we found that the S protein contains a hexapeptide motif that has a high similarity to an ITIM in a host protein, LIFR. Furthermore, this hexapeptide contains the site for the D614G mutation in SARS-CoV-2. Interestingly, in SARS-CoV-1, antibodies to this peptide were associated with ADE in in vitro experiments and led to lung induced injury in non-human primates 15 To date there is limited data on the role if any of LIF/ LIFR in COVID-19 71 . Yet, LIF is known to be an important player in recovery from pneumonia 31 and is elevated in the lungs of patients with ARDS 35 . Like all members of the IL-6 family of cytokines, LIF signals via STAT3 and utilizes glycoprotein 130 (gp130) as a receptor subunit 72 . LIF signaling is mediated by its binding to a high affinity receptor complex composed of a low affinity LIF binding chain (LIFR) and a high affinity converter subunit (gp130) 73 . Our results show that LIF is particularly elevated in mild COVID-19 pulmonary epithelial cells compared to severe or healthy cases while LIFR is elevated in both mild and severe cases (Figure 3; Supplementary Figure S8 ). Thus, it is possible that enhanced levels of LIF may lead to mild disease by compensating for potential interference of LIFR signaling by the viral spike ITIM sequence.

The classical view of the biological role of pulmonary epithelial cells is that they serve as a physical barrier to limit entry of pathogens or facilitate the removal of pathogens. Recent studies show that pulmonary epithelial cells play more complicated roles in inflammation, immunity and host defense 74 . Our results indicate that at least at the transcriptional level, pulmonary epithelial cells also express other key immunoreceptors including those containing ITAMs (FCGR2A), and ITIMs (LIFR, FCGR2B, LILRB1, NKG2A) implying that these cell types may also be involved in various immune responses. However, our study is limited by the use of transcriptional datasets which do not always reflect functional relevance. Interestingly, dexamethasone, a corticosteroid that improves survival of severely ill COVID-19 patients 75, 76 has been shown to enhance expression of FCGR2B both at the mRNA and protein levels 77, 78 . It is notable that FCGR2B expression was detectable in ciliated cells of healthy as well as severe COVID-19 cases but not in those of mild COVID-19 cases (Supplementary Figure S8) . It is also possible that subversion of host ITIMs not considered here could also contribute to immune dysregulation in COVID-19.

Dysregulation of other ITIM-containing proteins such as PD-L1 expressed by airway epithelial cells 79 or PECAM1 which is co-located with FCGR2A in platelets 80 may be especially important given the recent reports of vaccine induced thrombocytopenia in SARS-CoV-2 ChaAdOX1 vaccine recipients 81, 82 .

The observation that expression of ERVW-1 is induced in both mild and severe COVID-19 could also result in immune dysregulation and demonstrates a potential role of airway epithelial cells in pulmonary immune homeostasis given that ERV-derived dsRNA can trigger innate immune responses 63, 64, 83 . In relation to this, a recent study found that SARS-CoV-2 infection leads to increased expression of LINE-1, another type of retrotransposons in the human genome 84 .

Since LINE-1 encoded reverse transcriptase can also reverse transcribe HERV-W transcripts 85 , this may increase the likelihood for HERV-W pseudogene formation. There are at least 13 loci in the human genome encoding full length HERV-W envelope protein (Env) with only one of these on chromosome 7 encoding a functional protein, syncytin that is key to placenta formation through fusion of cytotrophoblasts 86 . HERV-W Env expression has been associated with multiple sclerosis 87 and type-1 diabetes 88 . Furthermore, Env is cytotoxic and induces production of autoantibodies that target it 89 . Such Env targeting autoantibodies in type-1 diabetes patients could cross-react with Env/ syncytin expressed in the lungs of COVID-19 patients. This could be one potential mechanism through which some comorbidities, for example, type-1 diabetes may be associated with severe COVID-19.

LIF and IL-6 share a signaling receptor (gp130) yet most studies to date on COVID-19 have focused only on IL-6 and a detailed assessment of the role of LIF /LIFR in the disease is lacking. IL-6 is one of the top cytokines that have been associated with COVID-19 disease severity yet clinical trials of therapeutic benefit of anti-IL-6 antibodies have yielded mixed results 90, 91 . A dissection of the role of LIF and IL-6 in COVID-19 could guide targeting of the distinct signaling pathways for these IL-6 family cytokines as a means to develop therapeutics against COVID-19. Given that LIFR is required for protection of lungs in pneumonia and its ligand LIF has been associated with acute respiratory distress syndrome (ARDS), comorbidities such as obesity 92, 93 , diabetes 94 , hypertension 95, 96 , stroke 97 and severe COVID-29 cases.

The Eukaryotic Linear Motif (ELM) resource server 23, 24 was used to scan the SARS-CoV-1 and 2 spike protein sequence for candidate and known functional motifs. To minimize false positive short linear motifs (SLIMs), we used filters that include contextual information on the location of the motif such that motifs occurring within globular domains are excluded. Detected ITIM sequences were manually verified to be consistent with ITIM regular expression (ILV)-x-x-Y-x-(LV). ITIM containing proteins in the human proteome were obtained from a previous study 30 .

Candidate genes for transcriptome analysis were selected based on their roles in i) SARS-CoV- Like the S protein, syncytin is a class I fusion protein 103 and its ligand in mice (Ly6E) was recently shown to impair SARS-CoV-2 membrane fusion 104 . Furthermore, HERV expression impacts innate immunity to exogenous viruses and some ERVs have been co-opted as regulators of innate immunity in non-human primates 83, 105 .

We used published single cell RNA-seq (scRNA-seq) data, for different tissues/organs, from the human cell atlas data portal (https://data.humancellatlas.org/) 47 genes detected, mitochondrial gene fraction<20% and at least 10,000 mapped UMI per cell for the quality control, target genes mean expression and initial exploratory analysis.

We used single cells that had at least 1000 genes detected, mitochondrial gene fraction<20% and at least 10,000 mapped UMI per cell. Each cell's total counts were normalized to 10,000, then log transformed, and significantly highly variable genes identified using in Seurat's mean 

Here we compiled a set of markers for each organ/tissue cell type as described in the UCSC cell browser (https://cells.ucsc.edu/ ). For each subpopulation calculated the overlap score between its top 100 markers and each cell type markers using Scanpy's marker_gene_overlap algorithm 62 with normalization set to the 'reference' set of markers.

Since the number of cells varied for each subpopulation, we subsampled 300 cells from each subpopulation and performed differential gene expression using Welch -t test using the genes counts with negative binomial noise model. 100 replications were carried out for each pairwise comparison between subpopulations. 

The cytokine storm and COVID-19

COVID-19 ARDS is characterized by a dysregulated host response that differs from cytokine storm and is modified by dexamethasone

Autoantibodies against type I IFNs in patients with life-threatening

Clinically identifiable autoreactivity is common in severe SARS-CoV-2 infection

Diverse functional autoantibodies in patients with

Molecular recognition of paired receptors in the immune system

Termination of immune activation: An essential component of healthy host immune responses

How ITAMs inhibit signaling

Viral Manipulation of Host Inhibitory Receptor Signaling for Immune Evasion

Bacterial Immune Evasion through Manipulation of Host Inhibitory Immune Signaling

How viruses hijack cell regulation

How pathogens use linear motifs to perturb host cell networks

Uncovering potential host proteins and pathways that may interact with eukaryotic short linear motifs in viral proteins of MERS, SARS and SARS2 coronaviruses that infect humans

Convergent evolution and mimicry of protein linear motifs in host-pathogen interactions

Immunodominant SARS coronavirus epitopes in humans elicited both enhancing and neutralizing effects on infection in non-human primates

Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection

Dengue Virus Infection Differentially Influence Antibody-Mediated RII Cytoplasmic Domains γ Human Fc Human FcgRII Cytoplasmic Domains Differentially Influence Antibody-Mediated Dengue Virus Infection

Involvement of the Fcγ receptor IIA cytoplasmic domain in antibody-dependent enhancement of dengue virus infection

Dengue virus compartmentalization during antibody-enhanced infection

Leukocyte immunoglobulin-like receptor B1 is critical for antibodydependent dengue

Synthetic peptides containing ITIM-like sequences of IREM-1 (CD300F) differentially regulate MyD88 and TRIF-mediated TLR signalling through activation of SHP and/or PI3K

CD300F Blocks Both MyD88 and TRIF-Mediated TLR Signaling through Activation of Src Homology Region 2 Domain-Containing Phosphatase 1

ELM -The database of eukaryotic linear motifs

ELM-the eukaryotic linear motif resource in 2020

Short linear motif candidates in the cell entry system used by SARS-CoV-2 and their potential therapeutic implications

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2. bioRxiv

Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear

An immunoreceptor tyrosine-based inhibition motif in varicella-zoster virus glycoprotein B regulates cell fusion and skin pathogenesis

Systematic identification of immunoreceptor tyrosine-based inhibitory motifs in the human proteome

Leukemia Inhibitory Factor Signaling Is Required for Lung Protection during Pneumonia

Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection

Cigarette Smoke Exposure Reduces Leukemia Inhibitory Factor Levels During Respiratory Syncytial Viral Infection

Myeloid-epithelial cross talk coordinates synthesis of the tissueprotective cytokine leukemia inhibitory factor during pneumonia

High levels of leukaemia inhibitory factor in ARDS

Sequential production of leukaemia inhibitory factor by blood cell culture in patients with ARDS

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?

The D614G mutation in SARS-CoV-2 Spike increases transduction of multiple human cell types

The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity

The D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity and decreases neutralization sensitivity to individual convalescent sera

The SARS-CoV-2 Spike Variant D614G Favors an Open Conformational State

The spike d614g mutation increases sars-cov-2 infection of multiple human cell types

SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo

Structural impact on SARS-CoV-2 spike protein by D614G substitution

Spike mutation D614G alters SARS-CoV-2 fitness

The human cell atlas

ScRNA-seq assessment of the human lung, spleen, and esophagus tissue stability after cold preservation

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

ACE2 Is the SARS-CoV-2 Receptor Required for Cell Entry

ACE2: The Major Cell Entry Receptor for SARS-CoV-2

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science (80-. )

Neuropilin-1 is a host factor for SARS-CoV-2 infection

Role That Each NKG2A Immunoreceptor Tyrosine-Based Inhibitory Motif Plays in Mediating the Human CD94/NKG2A Inhibitory Signal

Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity

IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity

SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes

A Single-Cell RNA Expression Map of Human Coronavirus Entry Factors

UMAP: Uniform manifold approximation and projection for dimension reduction

Fast unfolding of communities in large networks

Large-scale single-cell gene expression data analysis

Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses

Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses

Cellular sensing of extracellular purine nucleosides triggers an innate IFN-β response

Endogenous IFNβ expression predicts outcome in critical patients with COVID-19

Natural killer cell immunotypes related to COVID-19 disease severity

Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science (80-. )

Cross talk between inhibitory immunoreceptor tyrosine-based activation motif-signaling and toll-like receptor pathways in macrophages and dendritic cells

CD22 and Siglec-G in B cell function and tolerance

LIF and the lung's stem cell niche: Is failure to use LIF to protect against COVID-19 a grave omission in managing the pandemic?

Interleukin-6 family cytokines

Dimerization of the cytokine receptors gp130 and LIFR analysed in single cells

The innate immune function of airway epithelial cells in inflammatory lung disease

EMA endorses use of dexamethasone in COVID-19 patients on oxygen or mechanical ventilation

COVID-19 and Dexamethasone

High-dose dexamethasone shifts the balance of stimulatory and inhibitory Fcγ receptors on monocytes in patients with primary immune thrombocytopenia

Dexamethasone induces FCRIIB expression in RBL-2H3 cells

Expression of programmed death-1 ligand (PD-L) 1, PD-L2, B7-H3, and inducible costimulator ligand on human respiratory tract epithelial cells and regulation by respiratory syncytial virus and type 1 and 2 cytokines

Physical proximity and functional interplay of PECAM-1 with the Fc receptor FcγRIIa on the platelet plasma membrane

Thrombosis and Thrombocytopenia after

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

Regulatory evolution of innate immunity through co-option of endogenous retroviruses

SARS-CoV-2 RNA reverse-transcribed and integrated into the human genome

Processed Pseudogenes of Human Endogenous Retroviruses Generated by LINEs: Their Integration, Stability, and Distribution

From ancestral infectious retroviruses to bona fide cellular genes: Role of the captured syncytins in placentation

PHERV-W envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosis

A new therapeutic approach for type 1 diabetes: Rationale for GNbAC1, an anti-HERV-W-Env monoclonal antibody

Anti-HERV-W Env antibodies are correlated with seroreactivity against Mycobacterium avium subsp. paratuberculosis in children and youths at T1D risk

Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

Inhibition of hypothalamic leukemia inhibitory factor exacerbates diet-induced obesity phenotype

Effects of leukemia inhibitory factor receptor on the adipogenic differentiation of human bone marrow mesenchymal stem cells

Protection of leukemia inhibitory factor against high-glucose-induced human retinal endothelial cell dysfunction

Loss of myocardial LIF receptor in experimental heart failure reduces cardiotrophin-1 cytoprotection. A role for neurohumoral agonists?

The Role of Myokines and Adipokines in Hypertension and Hypertension-related Complications

Leukemia Inhibitory Factor Protects Neurons from Ischemic Damage via Upregulation of Superoxide Dismutase 3

Leukemia Inhibitory Factor Is Involved in Tubular Regeneration after Experimental Acute Renal Failure

Leukaemia Inhibitory Factor Stimulates Proliferation of Olfactory Neuronal Progenitors via Inducible Nitric Oxide Synthase

Leukemia inhibitory factor, interleukin-6, and their receptors are expressed transiently in the olfactory mucosa after target ablation

Expression of leukaemia inhibitory factor (LIF) receptor in human placenta: A possible role for LIF in the growth and differentiation of trophoblasts

Virus and eukaryote fusogen superfamilies

LY6E impairs coronavirus fusion and confers immune control of viral disease

Evolution: Endogenous viruses provide shortcuts in antiviral immunity

The authors declare no conflict of interest.

We are grateful to Dr. Carol Sibley (University of Washington) for the insightful discussions and feedback on this work.

All the results datasets and the accompanying code can be accessed as jupyter notebook from GitHub at https://github.com/SiwoResearch/SARS-CoV-2-Immunopathology